Pylera is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Allergan, Inc.. The primary component is Bismuth Subcitrate Potassium; Metronidazole; Tetracycline Hydrochloride.
| Product ID | 58914-601_5496a567-bd63-4063-a95a-7addc47665f1 |
| NDC | 58914-601 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Pylera |
| Generic Name | Bismuth Subcitrate Potassium, Metronidazole, Tetracycline Hydrochloride |
| Dosage Form | Capsule |
| Route of Administration | ORAL |
| Marketing Start Date | 2013-08-01 |
| Marketing Category | NDA / NDA |
| Application Number | NDA050786 |
| Labeler Name | Allergan, Inc. |
| Substance Name | BISMUTH SUBCITRATE POTASSIUM; METRONIDAZOLE; TETRACYCLINE HYDROCHLORIDE |
| Active Ingredient Strength | 140 mg/1; mg/1; mg/1 |
| Pharm Classes | Bismuth [CS],Bismuth [EPC],Nitroimidazole Antimicrobial [EPC],Nitroimidazoles [CS],Tetracycline-class Antimicrobial [EPC],Tetracyclines [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2013-08-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA050786 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2013-08-01 |
| Marketing Category | NDA |
| Application Number | NDA050786 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2013-08-01 |
| Ingredient | Strength |
|---|---|
| BISMUTH SUBCITRATE POTASSIUM | 140 mg/1 |
| SPL SET ID: | a762e164-b390-4e8c-bd46-bf6c31eeb486 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() PYLERA 78846616 3453776 Live/Registered |
APTALIS PHARMA CANADA ULC 2006-03-27 |